Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
How exactly did insulin become unaffordable? This is the question that Drew Pendergrass explores in a widely read piece for Harvard Political Review, which was published on January 22, 2018. Pendergrass begins by telling the story of Alec Raeshawn Smith, who recently died after an all-too-common practice: rationing insulin due to expense. Pendergrass then explores the sinister practices that have led to situations like Smith’s. For instance, he discusses price fixing between the major manufacturers, the lack of generic options, and the “twisted accounting” of the rebate-driven drug pricing system.
It’s the last item that seems to have most excited the diabetes online community. This may be because Pendergrass does such an exceptional job of unpacking such a convoluted scheme. In short, he explains how Pharmacy Benefit Managers (PBMs) and insurers pocket drug rebates from manufacturers that should be issued to patients. The tight-knit relationship between manufacturers, PBMs, and insurers negatively impacts all patients, but it has been especially detrimental for individuals with diabetes. There are a few reasons for this: these individuals need insulin to live, the drug costs are extraordinarily inflated, and there are no generic options.
http://insulinnation.com/living/is-the-publics-lack-of-empathy-to-blame-for-increased-insulin-costs/
Fred Banting must be spinning in his grave
It’s the last item that seems to have most excited the diabetes online community. This may be because Pendergrass does such an exceptional job of unpacking such a convoluted scheme. In short, he explains how Pharmacy Benefit Managers (PBMs) and insurers pocket drug rebates from manufacturers that should be issued to patients. The tight-knit relationship between manufacturers, PBMs, and insurers negatively impacts all patients, but it has been especially detrimental for individuals with diabetes. There are a few reasons for this: these individuals need insulin to live, the drug costs are extraordinarily inflated, and there are no generic options.
http://insulinnation.com/living/is-the-publics-lack-of-empathy-to-blame-for-increased-insulin-costs/
Fred Banting must be spinning in his grave